Grail, Backed by Jeff Bezos and Bill Gates, Files for IPO
Cancer diagnostic specialist Grail today filed for an initial public offering (IPO) on the Nasdaq, with the stock to trade under the ticker symbol GRAL. In its 2019 round of funding, Grail's valuation was estimated at $3.2 billion. Grail was spun out of gene-sequencing giant Illumina (NASDAQ: ILMN) four years ago.